Cargando…

Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis

BACKGROUNDS: As a systemic skeletal dysfunction, osteoporosis (OP) is characterized by low bone mass and bone microarchitectural damage. The global incidences of OP are high. METHODS: Data were retrieved from databases like Gene Expression Omnibus (GEO), GeneCards, Search Tool for the Retrieval of I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xing, Pei, Zhiwei, Hao, Ting, Ariben, Jirigala, Li, Siqin, He, Wanxiong, Kong, Xiangyu, Chang, Jiale, Zhao, Zhenqun, Zhang, Baoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610549/ https://www.ncbi.nlm.nih.gov/pubmed/36311708 http://dx.doi.org/10.3389/fimmu.2022.987937

Ejemplares similares

Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients
por: Del Bianco, Paola, et al.
Publicado: (2022)

Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning
por: Xu, Mingming, et al.
Publicado: (2023)

Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma
por: He, Qifan, et al.
Publicado: (2022)

CD80 and CTLA-4 as diagnostic and prognostic markers in adult-onset minimal change disease: a retrospective study
por: Zhao, Bing, et al.
Publicado: (2018)

The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy
por: Su, Zuhui, et al.
Publicado: (2021)

Exercise for osteoporosis: A literature review of pathology and mechanism
por: Zhang, Lin, et al.
Publicado: (2022)

Targeting STING: From antiviral immunity to treat osteoporosis
por: Gao, Zhonghua, et al.
Publicado: (2023)

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis
por: Zheng, Yang, et al.
Publicado: (2020)

Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts
por: Ma, Delin, et al.
Publicado: (2023)

TGF-β1 of no avail as prognostic marker in lyme disease
por: Schumann, Julia
Publicado: (2014)

Monitoring regulatory T cells as a prognostic marker in lung transplantation
por: Khan, Mohammad Afzal, et al.
Publicado: (2023)

Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus
por: Tan, Gongjun, et al.
Publicado: (2022)

Immunoporosis: Immunology of Osteoporosis—Role of T Cells
por: Srivastava, Rupesh K., et al.
Publicado: (2018)

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
por: Wu, Di, et al.
Publicado: (2021)

Peripheral enthesitis assessed by whole-body MRI in axial spondyloarthritis: Distribution and diagnostic value
por: Guo, Zikang, et al.
Publicado: (2022)

Immune landscape and prognostic gene signatures in gastric cancer: implications for cachexia and clinical outcomes
por: Sui, Xiangyu, et al.
Publicado: (2023)

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Screening diagnostic markers of osteoporosis based on ferroptosis of osteoblast and osteoclast
por: Cao, Zhihai, et al.
Publicado: (2023)

LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer
por: Zhang, Qiudan, et al.
Publicado: (2022)

C-reactive protein isoforms as prognostic markers of COVID-19 severity
por: Molins, Blanca, et al.
Publicado: (2023)

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Construction and validation of a cuproptosis-related prognostic model for glioblastoma
por: Zhang, Bohong, et al.
Publicado: (2023)

Immunoporosis: Role of Innate Immune Cells in Osteoporosis
por: Saxena, Yogesh, et al.
Publicado: (2021)

The synergistic effects of polyphenols and intestinal microbiota on osteoporosis
por: Wang, Keyu, et al.
Publicado: (2023)

Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance
por: Duan, Siqin, et al.
Publicado: (2022)

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes
por: Ceperuelo-Mallafré, Victòria, et al.
Publicado: (2022)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Complement C1s as a diagnostic marker and therapeutic target: Progress and propective
por: Ye, Jun, et al.
Publicado: (2022)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
por: Xia, Yan, et al.
Publicado: (2022)

Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma
por: Yang, Yang, et al.
Publicado: (2021)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis
por: Liang, Xiao, et al.
Publicado: (2022)

Serum CD203c+ Extracellular Vesicle Serves as a Novel Diagnostic and Prognostic Biomarker for Succinylated Gelatin Induced Perioperative Hypersensitive Reaction
por: Qi, Zheng, et al.
Publicado: (2021)

FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
por: Zhong, Anyuan, et al.
Publicado: (2021)

Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy
por: Hu, Wei-Ting, et al.
Publicado: (2023)

Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
por: Alosaimi, Bandar, et al.
Publicado: (2021)

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma
por: Liu, Yanli, et al.
Publicado: (2022)

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab
por: De Biasi, Sara, et al.
Publicado: (2023)

Construction and validation of a robust prognostic model based on immune features in sepsis
por: Zheng, Yongxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_apr2uuoihk7i6pdes2o3vacs1f